Mildly low platelets alone linked to modest blood disease risk
Ten-year blood disease risks were at most 4% in UK adults and 7% in Denmark, versus at most 2% with normal platelet and hemoglobin levels.
Our read
Biomarkers- Studied:
- Cohort study of 485,103 UK and Danish general population participants, 14 years; 11 years (Independent replication)
- What changed:
- 10 year blood disease risk was higher with mildly low platelets alone: ≤4% (UK), ≤7% (Denmark), versus ≤2% with normal counts
- The catch:
- UK records could miss mild nonmalignant blood diseases not requiring hospital admission
- In the record:
- The 11th paper on thrombocytopenia with results in people; 65 on record in all.
Editor of record: Boris Djordjevic · AgingResearch.News
Among 485,103 women and men from the UK and Denmark, a prospective cohort study examined health risks after blood tests. UK participants were aged 40–70; Danish participants were 20–100. Median follow-up was 14 and 11 years, respectively.
Platelets help blood clot. Mildly low platelet counts without low hemoglobin, the blood’s oxygen-carrying protein, were linked to higher relative risks of blood disease and death from blood disease. However, among adults aged 40–70, 10-year blood disease risks were at most 4% in the UK and 7% in Denmark, versus at most 2% with normal platelet and hemoglobin levels. The 10-year risk of dying from blood disease was below 1% in every age and sex group with mildly low platelets alone. Low platelet counts were also linked to higher overall death risk.
Why it matters
For older adults with incidentally detected low platelet counts, the authors said absolute risks may help guide discussions about referral to a blood specialist, further tests and follow-up.
Caveats
The authors note that they could not distinguish whether underlying diseases or frailty explained the higher death risk. Most participants were white, and people with previously diagnosed blood disorders were excluded.
From the paper
- Participants
We included 485 103 individuals from three independent prospective studies of the general population.
- Follow-up
Median follow-up was 14 years (range 0-16) in the UK cohort and 11 years (range 0-18) in the Danish cohort.
- Result
… individuals with isolated mild or moderate-severe thrombocytopenia had an increased relative risk of death from any cause in the UK cohort (multivariable adjusted hazard ratio 1.30, 95% confidence interval 1.21 to 1.39 for mild and hazard ratio 1.81, 1.54 to 2.12 for moderate-severe thrombocytopenia …
- Limitation
Hence we could not determine whether the increased risk of death from any cause in individuals with thrombocytopenia resulted from specific underlying diseases also causing thrombocytopenia, or whether thrombocytopenia was an unspecific marker of frailty.
Quoted word for word from the full text on bmjmedicine.bmj.com.
The paper
Copenhagen University Hospital-Rigshospitalet
BMJ Medicine, Nov 11, 2026, Open access, CC BY-NC
Comments
Be the first to comment.